Improving communication between patients and doctors in ovarian cancer care
Development and Pilot Testing of a Collaborative Agenda-Setting Intervention to Promote Patient-Centered Communication in Ovarian Cancer Care
This study is working to help people with advanced ovarian cancer have better conversations with their doctors, using new technology to make communication easier and improve their overall well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11077348 on NIH RePORTER |
What this research studies
This research aims to enhance patient-centered communication (PCC) for individuals with advanced ovarian cancer, who often face significant physical and psychological challenges. The project will develop and pilot test a new intervention that encourages patients and their healthcare providers to engage in more effective communication during clinical visits. By utilizing advanced technology like natural language processing, the study seeks to objectively assess communication behaviors, making it easier to identify areas for improvement. The ultimate goal is to improve the overall health-related quality of life for patients through better communication.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with advanced ovarian cancer who are seeking to improve their communication with healthcare providers.
Not a fit: Patients with early-stage ovarian cancer or those not receiving treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for patients with ovarian cancer by fostering better communication with their healthcare providers.
How similar studies have performed: While there have been successful interventions aimed at improving communication in cancer care, this specific approach using natural language processing is relatively novel.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Pozzar, Rachel — Dana-Farber Cancer Inst
- Study coordinator: Pozzar, Rachel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.